Palvella Therapeutics (PVLA) EPS (Weighted Average and Diluted) Growth (1y) (2021 - 2026)
Palvella Therapeutics (PVLA) EPS (Weighted Average and Diluted) Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
251.11% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-13.31% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
102.51% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-79.34% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
-103.05% |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
61.45% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Palvella Therapeutics |
1.42 Bn |
1.16 Bn |
- |
-62.16% |
| Date | Value |
|---|
| Mar 31, 2026 |
-62.16% |
| Dec 31, 2025 |
-1,000.00% |
| Sep 30, 2025 |
73.86% |
| Jun 30, 2025 |
65.18% |
| Mar 31, 2025 |
51.95% |
| Dec 31, 2024 |
-99.41% |
| Sep 30, 2024 |
54.71% |
| Jun 30, 2024 |
-168.23% |
| Jun 30, 2023 |
2,685.71% |
| Jun 30, 2022 |
44.00% |
| Mar 31, 2022 |
0.00% |
| Dec 31, 2021 |
50.00% |
| Sep 30, 2021 |
7.69% |
| Jun 30, 2021 |
-177.78% |
